Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trialAlyssa A Toorop, Zoé L. E. van Kempen, E.M.P.E. Zeinstra et al.|Journal of the Neurological Sciences|2024Cited by 6
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosisLiza M. Y. Gelissen, Zoé L. E. van Kempen, Alyssa A Toorop et al.|Journal of Neurology Neurosurgery & Psychiatry|2025Cited by 1